0
0 (0%)
Novaccess Global Inc. [XSNX]
Source:
Company Overview
NovAccess Global Inc. is a biopharmaceutical company that is developing novel immunotherapies to treat brain tumor patients in the United States with plans to expand globally. We specialize in cutting-edge research related to utilizing a patient’s own immune system to attack the cancer.
| Country | United States |
| Headquarters | chagrin falls, ohio |
| Phone Number | (213) 642-9268 |
| Industry | manufacturing |
| CEO | Dwain K. Irvin |
| Website | www.novaccessglobal.com |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | $0 |
| Operating Profit | $0 |
| Net Income | $0 |
| Net Cash | $-0 |
Profit Ratios
| Gross Margin | $0 |
| Operating Margin | |
| Profit as % of Revenues | |
| Profit as % of Assets | |
| Profit as % of Stockholder Equity |
Management Effectiveness
| Return on Equity | 7.2% |
| Return on Assets | -575.2% |
| Turnover Ratio | |
| EBITA |
Balance Sheet and Cash Flow Measures
| Total Assets | $0.1 |
| Total Liabilities | $6.9 |
| Operating Cash Flow | $-0.1 |
| Investing Cash Flow | $0 |
| Financing Cash Flow | $0.1 |
